Health Tech, or digital health, helps us understand and take control of our own health. But we also cover more traditional health news like medicines, vaccines and medical procedures.
Researchers have developed a "universal vaccine" in the form of a nasal spray that in animal experiments protected against virtually all tested viruses, bacteria and even allergens. The method puts immune cells in the lungs in a heightened state of readiness.
In a two-year experiment in Singapore, the number of wild mosquitoes decreased by 77 percent in areas where Wolbachia-infected male mosquitoes were released. Residents in treated neighborhoods had approximately 70 percent lower risk of developing symptomatic dengue.
The system identified new reaction compositions that reduced protein production costs by 40 percent compared to previous methods. Cell-free protein synthesis is used to manufacture proteins for pharmaceuticals, diagnostics, and industrial processes.
A study with over 100,000 women shows that AI-supported mammography screening is equivalent to or better than traditional double reading. Sensitivity increased from 73.8 percent to 80.5 percent with AI support. Fewer cancer cases with unfavorable characteristics were missed in the AI group.
The model was trained on nearly 600,000 hours of sleep data from 65,000 participants and shows high accuracy for cancer, heart disease, and dementia, among others. The AI model performs as well as or better than today's leading methods for sleep analysis.
A gene therapy has for the first time been shown to slow Huntington's disease by 75 percent after three years in a clinical trial. The results provide proof that the disease can be treated, opening possibilities for other neurodegenerative conditions as well.
Trachoma is the world's leading infectious cause of blindness. The number of people requiring interventions against trachoma has dropped from 1.5 billion to 97.1 million since 2002. Over 1.1 billion doses of antibiotics have been donated to combat the disease.
Researchers in Tanzania have for the first time in Africa created genetically modified mosquitoes that prevent the malaria parasite from developing. The modified mosquitoes contain naturally occurring molecules from frogs and bees that effectively stop the parasite Plasmodium falciparum.
All eight patients with multiple myeloma in two clinical trials had their cancer cells eliminated from the bone marrow. The method could make CAR-T treatment faster and cheaper. Several pharmaceutical companies are now investing in the technology, and more clinical trials are underway.